(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

29 oct 2018 7:00 a.m. - 29 oct 2018 5:30 p.m.

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

Canadian Pharmacovigilance and Risk Management Strategies Conference

Perspectiva general

DIA’s Canadian Pharmacovigilance and Risk Management Strategies Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.

Great learning opportunity with Health Canada speakers to get the latest updates and be able to directly ask them questions.
-Previous Attendee

Very informative. I liked how we had the opportunity to discuss issues/topics with Health Canada.
-Previous Attendee

Highlights

  • Risk management for opioids
  • Cybersecurity and implications for pharmacovigilance
  • Round table with Inspector
  • Canada vigilance update by Health Canada

Travel Once, Learn Twice!
This year the Canadian Pharmacovigilance and Risk Management Strategies Conference will be co-located with the DIA Annual Canadian Meeting. Maximize your education and time by attending both! Save* $150 when you register for both!
*You must register for both events at the same time. 

Featured

Want to learn more about Canadian Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Obtener más información

¿Quiénes deben asistir?

Professionals involved in:
  • Regulatory
  • Policy
  • Clinical trial disclosure policies and compliance
  • Clinical operations or clinical research
  • Medical writing and communications
  • Legal
  • Market access

    • Objetivos de aprendizaje

    At the conclusion of this conference, participants should be able to:

    • Describe the current Canadian regulatory framework for pharmacovigilance
    • Identify current pharmacovigilance issues facing Marketing Authorization Holders in Canada
    • Describe the challenges of cybersecurity and strategies to cybersecurity implementation

    Comité del programa

    • Rita Cassola, RPh
      Rita Cassola, RPh Executive Director PV
      Certus PV Services Inc, Canada
    • Marcia Bailey, BSN, MHS, RN
      Marcia Bailey, BSN, MHS, RN Safety Evaluation and Risk Management Scientific Director
      GSK, Canada
    • Colin D'Cunha, MD, MHS, FRCPC
      Colin D'Cunha, MD, MHS, FRCPC Director, Global Medical Affairs
      Apotex Inc., Canada
    • Melissa Hunt, MSc
      Melissa Hunt, MSc Director
      Health Canada, Canada
    • Marc Poitras, PhD, MBA
      Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
      Health Canada, Canada

    Digital Learning Catalog

    DIA Learning: eLearning Soultions
    Download

    ¿Tiene una cuenta?

    Be informed and stay engaged.

    Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.